We employed correlation analysis between IL6 pathway-related genes and overall survival (OS) time in C1-GBM, as well as G2/M checkpoint pathway-related genes and OS time in C2-GBM, to select candidate variables (p < 0.05). The gene discussed is IL6; the disease is glioblastoma.